Monday, April 11, 2016

Venetoclax approved

Venetoclax has been approved!!!

Horray, just came out of a patients room and told her this would be approved by the next time I saw her.  I guess I was wrong, it was already approved!

This is a fantastic drug and one of the most effective agents ever in CLL.  See the press release (click here).  Several years ago, I wrote about BCL-2 as a target (click here)

I have written about tumor lysis previously (click here) and it is worth a read.

This drug is currently approved for patients with relapsed CLL that has 17P deletion - but like ibrutinib will become more and more available as new clinical trials read out.

More later if I can find time to post

3 comments:

  1. Find the time! Thoughts on Combinations, which drug first etc.?

    ReplyDelete
  2. Hey Doc, would love to see a post comparing Venetoclax to Imbruvica for us if you can. Details of the differences and response rate comparisons would really be awesome for us non medical folks.

    ReplyDelete
  3. Great news!!! I really hope you can find time to post more about it

    ReplyDelete

All comments will be reviewed / moderated before posting.

Comments about alternative therapies will not be posted

Due to limitations, I am unable to answer questions about individual medical situations

Please be respectful of one another.